Company Overview of Raven Biotechnologies, Inc.
As of July 17, 2008 Raven Biotechnologies, Inc. was acquired by MacroGenics, Inc. Raven Biotechnologies, Inc., a biotechnology company, focuses on the development of monoclonal antibody therapeutics for treating cancer. Its lead product candidate, RAV12, targets adenocarcinomas and used for the treatment of gastrointestinal, lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. Raven Biotechnologies, Inc. was founded in 1999 and is based in South San Francisco, California.
One Corporate Drive
South San Francisco, CA 94080
Founded in 1999
Key Executives for Raven Biotechnologies, Inc.
Raven Biotechnologies, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|Eutropics Pharmaceuticals, Inc.||United States|
|Biothera Holding Corp.||United States|
|SolaranRx, Inc.||United States|
|CSL Behring LLC||United States|
|Nucleonics, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Raven Biotechnologies, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.